Clin2
NCT06710899Possibly a fitNot yet recruiting

Vitamin C and Hiprex for repeat urinary tract infections

Urinary Tract Infections

Treatments studied

Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests whether taking vitamin C together with a medicine called Hiprex (methenamine hippurate) helps prevent repeat urinary tract infections (UTIs) in women. If you are eligible, you would take these two treatments and track your urine acidity using emailed results to see how well they work.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are a woman aged 18 or older.
  • You have had frequent, confirmed urinary tract infections (UTIs) – at least 2 in 6 months or 3 in a year.
  • You are not pregnant or breastfeeding, and if you could become pregnant, you agree to use effective birth control.
  • You are not currently taking daily antibiotics or the medicine Hiprex (methenamine hippurate).
  • You do not have a urinary catheter or use self-catheterization, and you have no other correctable urinary tract problems (like kidney stones).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07186465Recruiting· Phase 4
Preventing repeat bladder infections in postmenopausal women

This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.

Bangkok, Phayatai Ratchathewi
NCT04095572Recruiting· Phase 4
Prevention options for recurring bladder infections in women

This trial studies different ways to prevent repeated bladder (urinary tract) infections in women. It may help people who keep getting these infections by testing safer or more effective prevention strategies.

Basel
NCT05488340Recruiting· Phase 2
Study drug for hard-to-treat bladder infection in women

This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.

Fresno, California
NCT07507851Not yet recruiting
Acupuncture to prevent repeat bladder infections in women

This study tests whether electroacupuncture (a type of acupuncture with mild electric pulses) can help prevent repeat urinary tract infections (bladder infections) in women. If you've had several bladder infections, this treatment might reduce how often they come back.

Beijing
NCT07202949Recruiting· Phase 2
Extended antibiotics with methenamine for chronic urinary tract infection

This trial compares a longer, higher-dose antibiotic course combined with methenamine hippurate (a urinary antiseptic) against standard care (low-dose antibiotics or methenamine alone) for women with chronic urinary tract infections. It aims to see if the extended treatment is more effective at relieving persistent symptoms.

London
NCT05652374Recruiting· Phase 4
Gag therapy for repeat bladder infections, compared to standard antibiotics

This trial tests a therapy (called GAG therapy) to prevent repeat urinary tract infections (UTIs) in adult women. It compares how similar the results are to a well-known antibiotic standard (nitrofurantoin) to see if it works reliably.

Nijmegen, Gelderland

Hear when a new Urinary Tract Infections trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.